The latest Ebola virus (EBOV) epidemic spread rapidly through Guinea, Sierra Leone, and Liberia, creating a global public health crisis and accelerating the assessment of experimental therapeutics and vaccines in clinical trials. One of those vaccines is based on recombinant vesicular stomatitis virus expressing the EBOV glycoprotein (VSV-EBOV), a live-attenuated vector with marked preclinical efficacy. Here, we provide the preclinical proof that VSV-EBOV completely protects macaques against lethal challenge with the West African EBOV-Makona strain. Complete and partial protection was achieved with a single dose given as late as 7 and 3 days before challenge, respectively. This indicates that VSV-EBOV may protect humans against EBOV infections in West Africa with relatively short time to immunity, promoting its use for immediate public health responses.
Original Source [2]
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/vsv-ebov-rapidly-protects-macaques-against-infection-201415-ebola-virus-outbreak
[2] https://www.sciencemag.org/content/early/2015/08/05/science.aab3920.full.pdf
[3] http://admin.indiaenvironmentportal.org.in/category/author/andrea-marzi
[4] http://admin.indiaenvironmentportal.org.in/category/author/shelly-j-robertson
[5] http://admin.indiaenvironmentportal.org.in/category/author/elaine-haddock-et-al
[6] http://admin.indiaenvironmentportal.org.in/category/journal/science-express
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ebola-virus-disease-ebola-hemorrhagic-fever
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/research
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/monkey
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/africa
